Latest HALO reports update at 2024-05-07: 2024-Q1 ∙ 2023-Q4 ∙ 2023-Q1
  1. Home
  2. Stock quotes
  3. Halozyme Therapeutics
  4. Financial Ratios
  5. EV/EBITDA Ratio
Halozyme Therapeutics logo
Halozyme Therapeutics HALO
$ 49.5 -0.24%
mail-toReport an Error

Halozyme Therapeutics EV/EBITDA Ratio 2011-2024 | HALO

Annual EV/EBITDA Ratio Halozyme Therapeutics

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
17.2 48 -48.6 -35.3 31.9 -19.6 -43.5 -28.4 -23 -13.7 -55.4

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
48 -55.4 -15.5